000 | 01062 a2200277 4500 | ||
---|---|---|---|
005 | 20250516161143.0 | ||
264 | 0 | _c20140227 | |
008 | 201402s 0 0 eng d | ||
022 | _a1759-4804 | ||
024 | 7 |
_a10.1038/nrrheum.2013.113 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHerrero-Beaumont, Gabriel | |
245 | 0 | 0 |
_aOsteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agents. _h[electronic resource] |
260 |
_bNature reviews. Rheumatology _cAug 2013 |
||
300 |
_a448-50 p. _bdigital |
||
500 | _aPublication Type: News; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOsteoarthritis, Knee _xdrug therapy |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
700 | 1 | _aRoman-Blas, Jorge A | |
773 | 0 |
_tNature reviews. Rheumatology _gvol. 9 _gno. 8 _gp. 448-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrrheum.2013.113 _zAvailable from publisher's website |
999 |
_c22919854 _d22919854 |